SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-003111
Filing Date
2020-09-11
Accepted
2020-09-11 16:27:22
Documents
64
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmacyte_10q-073120.htm 10-Q 408575
2 RIGHT OF FIRST REFUSAL AGREEMENT pharmacyte_ex1001.htm EX-10.1 20883
3 AMENDMENT NO. 1 TO RIGHT OF FIRST REFUSAL AGREEMENT pharmacyte_ex1002.htm EX-10.2 9426
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER pharmacyte_ex3101.htm EX-31.1 9070
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER pharmacyte_ex3102.htm EX-31.2 9050
6 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4397
7 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4906
  Complete submission text file 0001683168-20-003111.txt   3150124

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE pmcb-20200731.xml EX-101.INS 564662
9 XBRL SCHEMA FILE pmcb-20200731.xsd EX-101.SCH 37703
10 XBRL CALCULATION FILE pmcb-20200731_cal.xml EX-101.CAL 41824
11 XBRL DEFINITION FILE pmcb-20200731_def.xml EX-101.DEF 162720
12 XBRL LABEL FILE pmcb-20200731_lab.xml EX-101.LAB 258274
13 XBRL PRESENTATION FILE pmcb-20200731_pre.xml EX-101.PRE 237586
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 201171273
SIC: 2836 Biological Products, (No Diagnostic Substances)